Dudediligence.

Vivos Therapeutics, Inc

VVOSNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Price
FilingsNewest: 8-K, Auditor changeSep 30 →Insiders2 insiders bought $1.8M in 2 open-market buys. No sales.→HoldersGeode 0.6%IHT Wealth 0.5%Vanguard 0.4%→Financing →PeersClosest companies: NRXS, VTAK, OBIO→

From the filings

Figures

Revenue
$20.9Mlast 12 months
Net income
−$25.5Mlast 12 months
Operating cash flow
−$17.5Mlast 12 months
Cash and equivalents
$1.8Mat the last balance sheet
Total debt
$8.1Mat the last balance sheet
Shares outstanding
14.5M shareson issue
Every year and quarter →